Dicerna Pharmaceuticals
Utility Patents

Last updated:

List of all Dicerna Pharmaceuticals patents 34 in total

Status Patent
Grant
Utility: Extended dicer substrate agents and methods for the specific inhibition of gene expression External link
Filling date: 9 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: 4'-phosphate analogs and oligonucleotides comprising the same External link
Filling date: 9 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: Extended dicer substrate agents and methods for the specific inhibition of gene expression External link
Filling date: 9 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Compositions comprising reversibly modified oligonucleotides and uses thereof External link
Filling date: 9 Sep 2025 Issue date: 19 Jul 2022
Grant
Utility: Extended dicer substrate agents and methods for the specific inhibition of gene expression External link
Filling date: 9 Sep 2025 Issue date: 14 Jun 2022
Grant
Utility: Therapeutic inhibition of lactate dehydrogenase and agents therefor External link
Filling date: 9 Sep 2025 Issue date: 14 Jun 2022
Grant
Utility: Process for formulating an anionic agent External link
Filling date: 9 Sep 2025 Issue date: 7 Jun 2022
Grant
Utility: Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 26 Apr 2022
Grant
Utility: Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 26 Apr 2022
Grant
Utility: Methods and compositions for inhibiting expression of LDHA External link
Filling date: 9 Sep 2025 Issue date: 29 Mar 2022
Grant
Utility: Methods for treating hepatitis B infection External link
Filling date: 9 Sep 2025 Issue date: 15 Mar 2022
Grant
Utility: Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Methods and compositions for the specific inhibition of transthyretin (TTR) by double stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 20 Jul 2021
Grant
Utility: Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Amine cationic lipids and uses thereof External link
Filling date: 9 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Methods for treating hepatitis B infection External link
Filling date: 9 Sep 2025 Issue date: 6 Jul 2021
Grant
Utility: Methods for treating hepatitis B infection External link
Filling date: 9 Sep 2025 Issue date: 6 Jul 2021
Grant
Utility: Beta catenin nucleic acid inhibitor molecule External link
Filling date: 9 Sep 2025 Issue date: 18 May 2021
Grant
Utility: Extended dicer substrate agents and methods for the specific inhibition of gene expression External link
Filling date: 9 Sep 2025 Issue date: 22 Dec 2020
Grant
Utility: Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 24 Nov 2020
Grant
Utility: Extended dicer substrate agents and methods for the specific inhibition of gene expression External link
Filling date: 9 Sep 2025 Issue date: 17 Nov 2020
Grant
Utility: Compositions and methods for the treatment of a beta-catenin-associated disease or disorder External link
Filling date: 9 Sep 2025 Issue date: 3 Nov 2020
Grant
Utility: Methods for treating hepatitis B infection External link
Filling date: 9 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Therapeutic inhibition of lactate dehydrogenase and agents therefor External link
Filling date: 9 Sep 2025 Issue date: 11 Aug 2020
Grant
Utility: Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 23 Jun 2020
Grant
Utility: Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Compositions and methods for inhibiting HMGB1 expression External link
Filling date: 9 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Methods and compositions for the specific inhibition of .beta.-catenin by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 7 Apr 2020
Grant
Utility: Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 6 Aug 2019

Showing 1 to 34 of 34 patents.